PETS PetMed Express Inc.

PetMed Express, Inc. Sets Fiscal First Quarter 2024 Earnings Call

PetMed Express, Inc. Sets Fiscal First Quarter 2024 Earnings Call

DELRAY BEACH, Fla., July 17, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health Expert™ will hold a conference call on Monday, July 31, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2023. Financial results will be issued in a press release prior to the call.

PetMeds’ management will host the conference call, followed by a question and answer period.

Date: Monday, July 31, 2023

Time: 4:30pm Eastern time (1:30pm Pacific time)

U.S. dial-in number: 877-407-0789

International number: 201-689-8562

Webcast:

Please call the conference telephone number 5-10 minutes prior to the start time. If you have any difficulty connecting with the conference call, please contact MZ Group at 561-374-0177.

A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through August 14, 2023.

Toll-free replay number: 844-512-2921

International replay number: 412-317-6671

Replay passcode: 13740086

About PetMed Express

Founded in 1996, PetMeds is Your Trusted Pet Health Expert™, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at .

Forward-Looking Statements

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2023. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

Investor Contact:

MZ North America

Brian M. Prenoveau, CFA



(561) 489-5315



EN
17/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

 PRESS RELEASE

PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing R...

PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DELRAY BEACH, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS), today announced that on September 9, 2025, the Compensation and Human Capital Committee of the Board of Directors approved an award of 15,000 shares of restricted common stock to Ali Khan, the Company’s newly hired Chief Information Security Officer, as a material inducement to employment. The award was granted pursuant to PetMeds’ 2024 Inducement Incentiv...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 16, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

PetMed Express, Inc. Announces Management Changes

PetMed Express, Inc. Announces Management Changes DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D’Elia, have resigned from their positions and employment with the Company. As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company’s Board of Directors (the “Board”), has assumed the role of Interim Chief Executive Officer, and Douglas Krulik, the Company’s Chief Acc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch